How does ProAir Respiclick (albuterol) work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How ProAir RespiClick (Albuterol) Works

ProAir RespiClick works by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, causing relaxation and bronchodilation, which improves airflow in patients with obstructive airway diseases like asthma. 1

Mechanism of Action

ProAir RespiClick contains albuterol, a short-acting beta-2 agonist (SABA) that:

  • Stimulates adenyl cyclase, the enzyme that catalyzes formation of cyclic-3',5'-adenosine monophosphate (cyclic AMP) from adenosine triphosphate (ATP) 1
  • The increased cyclic AMP mediates bronchial smooth muscle relaxation 1
  • Preferentially affects beta-2 adrenergic receptors (which predominate in bronchial smooth muscle) compared to beta-1 receptors 1
  • Provides rapid bronchodilation with minimal side effects 2

Pharmacokinetics

  • Onset of action: Within 5 minutes after inhalation 2, 1
  • Peak effect: 30-60 minutes 2
  • Duration of action: 4-6 hours 2
  • Absorption: Less than 20% of a single dose is absorbed following nebulizer administration 1
  • Metabolism: Not a substrate for cellular uptake processes for catecholamines or catechol-O-methyl transferase, contributing to its longer duration of action compared to isoproterenol 1
  • Elimination: Most of the absorbed dose is recovered in urine within 24 hours 1

Clinical Effects

ProAir RespiClick produces:

  • Significant improvement in pulmonary function (FEV1) within 5 minutes 1
  • Maximum average improvement in pulmonary function at approximately 1 hour 1
  • Clinically significant improvement (defined as ≥15% increase in FEV1 over baseline) for 3-4 hours in most patients, and up to 6 hours in some 1

Delivery System Specifics

ProAir RespiClick is a breath-actuated multidose dry powder inhaler (MDPI) that:

  • Does not use chlorofluorocarbon (CFC) propellants, which harm the ozone layer 3
  • Instead uses hydrofluoroalkane (HFA) propellants, which have no ozone-depleting effects 3
  • Delivers the same amount of drug per puff with similar particle size distribution as older CFC-based inhalers 3

Clinical Applications

ProAir RespiClick is indicated for:

  1. Quick relief of acute asthma symptoms 4
  2. Prevention of exercise-induced bronchospasm when used 15 minutes before exercise 4

Important Clinical Considerations

  • ProAir RespiClick should be used less than daily on average for symptom relief 4
  • Increasing use of albuterol (more than twice weekly) for symptom control generally indicates inadequate asthma control and the need for controller medication 2
  • Regular use exceeding twice weekly for symptom control (not for prevention of exercise-induced bronchospasm) indicates the need for initiating or intensifying anti-inflammatory therapy 4, 2

Safety Profile

  • Side effects are dose-related and more common with systemic (oral/IV) than inhaled administration 5
  • Potential side effects include:
    • Cardiovascular: tachycardia, increased pulse pressure 5
    • Metabolic: decreased plasma potassium, increased glucose 5
    • Musculoskeletal: skeletal muscle tremor 5

Common Pitfalls to Avoid

  1. Overreliance on rescue therapy: Using ProAir RespiClick more than twice weekly for symptom control suggests inadequate asthma management and need for controller medications 2

  2. Improper inhaler technique: Proper technique is essential for effective medication delivery 2

  3. Using for anaphylaxis management: While ProAir RespiClick may provide adjunctive therapy for wheezing during anaphylaxis, it does not replace epinephrine as the primary treatment 2

  4. Oral vs. inhaled administration: Oral albuterol is less potent, has slower onset, and more side effects than inhaled formulations 2

ProAir RespiClick remains a cornerstone of rescue therapy for asthma, though recent evidence suggests that in some patients with inflammatory components, combining with inhaled corticosteroids may be more efficacious 6.

References

Guideline

Asthma Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albuterol HFA for the management of obstructive airway disease.

Expert review of respiratory medicine, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Albuterol: Still first-line in rescue therapy?

JAAPA : official journal of the American Academy of Physician Assistants, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.